Compare Godaddy Inc (GDDY) vs McKesson Corporation (MCK) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Godaddy Inc vs McKesson Corporation — how do they compare? Godaddy Inc trades at $104.37 (market cap $13.07B), while McKesson Corporation trades at $938.84 (market cap $108.46B). The key difference: McKesson Corporation is far larger — about 8.3× Godaddy Inc's market cap, and McKesson Corporation pays a 0.4% dividend while Godaddy Inc pays none. Which is the better fit depends on your goals — on Pluang, investors hold Godaddy Inc for 64 Days and McKesson Corporation for 74 Days on average.
| GDDY | MCK | |
|---|---|---|
Market Cap | $13.07B | $108.46B |
Volume | 1,831,274 | 712,607 |
Sector | Technology | Health |
52-Week High | $135.18 | $995.69 |
52-Week Low | $75.07 | $725.17 |
Typical Hold Time | 64 Days | 74 Days |
Enterprise Value | $15.75B | $115.00B |
Dividend Yield | — | 0.4% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
GoDaddy (GDDY) trades at $103.19, up 6.15% with strong technical momentum and bullish moving average signals. The company demonstrates solid fundamentals with revenue growth to $4.95B in 2025, consistent earnings beats, and healthy profitability metrics including 63.8% gross margin. However, the stock faces significant headwinds from multiple securities class action lawsuits alleging misrepresentation of domain contract terms, creating investor uncertainty despite positive operational performance.
While GoDaddy's operational strength and earnings consistency support a constructive outlook, the legal overhang from securities litigation presents substantial near-term risk. Analyst consensus remains positive with 57.9% buy ratings and a $96.20 price target, but investors should weigh strong fundamentals against potential legal liabilities and stock volatility from ongoing court proceedings.
McKesson (MCK) trades at $930.25, up 2.19% today, with a bullish technical outlook and strong analyst support. The stock shows consistent earnings beats, with Q2 2026 EPS of $9.93 surpassing the $9.56 estimate. Revenue growth is robust, reaching $359.05B in 2025, though net margins are thin at 1.12%. Recent news highlights a key distribution extension with CVS Health through 2032, reinforcing long-term visibility.
The outlook is positive, driven by operational strength and strategic partnerships, but investors face risks from margin pressure and drug pricing uncertainty. With 81% of analysts rating it Buy and a consensus target of $956.43, the stock offers upside, though high RSI levels suggest near-term caution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Godaddy Inc
GoDaddy is a provider of domain registration and aftermarket services, website hosting, security, design, and business productivity tools, commerce solutions, and domain registry services. The company primarily targets micro- to small businesses, website design professionals, registrar peers, and domain investors. Since acquiring payment processing platform Poynt in 2021, the company has expanded into omnicommerce solutions, including offering an online payment gateway and offline point-of-sale devices.
Read more on GDDY →About McKesson Corporation
McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →
